German Regulator’s Ties to BioNTech Under Scrutiny Amid COVID Vaccine Toxicity Questions Given the economic significance of BioNTech’s success for the German economy, allowing a German regulator — the Paul Ehrlich Institute — to approve Pfizer-BioNTech’s COVID-19 vaccine for all European Union member states raises conflict of interest questions. By Brownstone Institute Miss a day, miss a lot. Subscribe to The Defender’s Top News of the Day. …Source
Related posts:
Video: DARPA Is Working On COVID Vaccine, Implantable Microchip To Detect Virus
HR 6666: Congress Introduces Bill To Allow Government To Mass Test Americans For COVID-19 In Their H...
Thousands of Australians with unpaid fines for breaking Covid rules have their homes seized, bank ac...
Brave Judge Rules Cops Must Return Cash Seized Under Civil Asset Forfeiture—Or Go to Jail
Free Inquiry R.I.P. | You can tell that the US presidential election was stolen the same way that yo...
Lisbon Court Rules Only 0.9% Of ‘Verified Cases’ Died Of COVID, Numbering 152, Not 17,000 Claimed